SLC35G1

Across TCGA pan-cancer cohorts, SLC35G1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated SLC35G1 data layer compared with 2 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SLC35G1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC35G1 expression acts as an unfavorable survival marker, although some lineages such as LUSC and UCS show a favorable association.

ACC, LUSC, and UCS are the cancer types where SLC35G1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.309	0.839	<.001	78	view →
LUSC	DFS	Tertile	All	0.821	0.706	<.001	69	view →
UCS	OS	Median	IV	0.844	0.234	.005	52	view →
UVM	DFS	Quartile	III,IV	0.323	0.945	<.001	47	view →
COAD	DFS	Median	IV	0.226	0.679	<.001	38	view →
LGG	DFS	Median	All	0.456	0.274	<.001	38	view →
LAML	DFS	Median	All	0.246	0.483	.002	36	view →
ESCA	DFS	Tertile	III,IV	0.285	0.472	.013	35	view →
LIHC	OS	Tertile	II,III,IV	0.626	0.826	.004	28	view →
GBM	OS	Quartile	All	0.636	0.246	.001	25	view →
KIRP	OS	Median	II,III,IV	0.345	0.696	.008	24	view →
BLCA	DFS	Quartile	II,III,IV	0.274	0.487	.009	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

SLC35G1–ACC (OS)

Open the ACC breakdown →